Trial Profile
Avanz Phleum Pratense Maintenance Dose.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 27 Aug 2014
Price :
$35
*
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Allergic rhinoconjunctivitis
- Focus Therapeutic Use
- Sponsors ALK-Abello
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Sep 2011 Additional location Denmark added as reported by ClinicalTrials.gov.